The CDIATM Methcathinone Colloidal Gold Test Cassette (Urine) is a lateral flow chromatographic immunoassay for the detection of methcathinone and its metabolites in human urine.
Methcathinone antigen is coated on the test region of the nitrocellulose membrane of the strips, and methcathinone antibody is labeled with colloid gold. During a test, the colloid gold labeled antibody coated in the strip move forward along the membrane, and a red line will show up when the antibody gathers with the antigen in the test line; if methcathinone in the sample is over the detection limit, line T is blank; on the other wise, if methcathinone in the sample is less than the detection limit, line T is red.
Methcathinone is a monoamine alkaloid and psychoactive stimulant, a substituted cathinone. It is used as a recreational drug due to its potent stimulant and euphoric effects and is considered to be addictive, with both physical and psychological withdrawal occurring if its use is discontinued after prolonged or high-dosage administration. It is usually snorted, but can be smoked, injected, or taken orally. Methcathinone is listed as a Schedule I controlled substance by the Convention on Psychotropic Substances and the United States' Controlled Substances Act, and as such it is not considered to be safe or effective in the treatment, diagnosis, prevention, or cure of any disease, and has no approved medical use. Possession and distribution of methcathinone for the purpose of human consumption is illegal under any/all circumstances in the United States and is either illegal or highly regulated in most jurisdictions world-wide. The CDIATM Methcathinone Colloidal Gold Test Cassette (Urine) is a rapid urine-screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of methcathinone in urine. The CDIATM Methcathinone Colloidal Gold Test Cassette (Urine) yields a positive result when the methcathinone in urine exceeds 500 ng/mL.